Insulet Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Insulet Corp 公司

Insulet Corporation 是一家医疗设备公司。该公司主要从事为胰岛素依赖型糖尿病患者开发、制造和销售其持续胰岛素输送系统。Omnipod 系统包括 Omnipod 5 自动胰岛素输送系统 (Omnipod 5)、Omnipod DASH 胰岛素管理系统、Omnipod 胰岛素管理系统和 Omnipod GO。该公司还为安进公司生产用于 Neulasta Onpro 套件的胶囊，该套件是安进公司 Neulasta 的输送系统。Omnipod 平台提供持续胰岛素输送，可提供胰岛素泵治疗的各种益处，而无需传统泵所需的外部管道。小巧、轻便、自粘式一次性无管 Omnipod 设备 (Pod) 可佩戴在多个位置，包括腹部、臀部、上臂后部、大腿上部或下背部，并通过小型柔性管将胰岛素输送到体内。Omnipod 5 包括嵌入在 Pod 中的 AID 算法。

Insulet Corp简介



公司代码PODD

公司名称Insulet Corp

上市日期May 15, 2007

CEOMs. Ashley Mcevoy

员工数量3900

证券类型Ordinary Share

年结日May 15

公司地址100 Nagog Park

城市ACTON

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编01720-3440

电话19786007000

网址https://www.omnipod.com

公司代码PODD

上市日期May 15, 2007

CEOMs. Ashley Mcevoy

Insulet Corp公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

14.85K

-8.50%

Mr. Eric Benjamin

Chief Operating Officer

10.47K

-28.94%

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

--

Mr. Prem Singh

Senior Vice President - Global Operations

3.56K

-16.16%

Dr. Luciana Borio, M.D.

Independent Director

3.09K

-13.48%

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.89K

+36.78%

名称

名称/职务

职务

持股

持股变动

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

14.85K

-8.50%

Mr. Eric Benjamin

Chief Operating Officer

10.47K

-28.94%

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

业务USD

名称

营收

占比

U.S.Omnipod

453.20M

69.82%

International Omnipod

185.80M

28.62%

Drug Delivery

10.20M

1.57%

地区USD

名称

营收

占比

United States

463.30M

71.38%

All Other

185.80M

28.62%

业务

地区

业务USD

名称

营收

占比

U.S.Omnipod

453.20M

69.82%

International Omnipod

185.80M

28.62%

Drug Delivery

10.20M

1.57%

股东统计

更新时间: 8月19日周二

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

12.33%

Fidelity Management & Research Company LLC

9.74%

Capital Research Global Investors

6.73%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.34%

其他

60.68%

持股股东

占比

The Vanguard Group, Inc.

12.33%

Fidelity Management & Research Company LLC

9.74%

Capital Research Global Investors

6.73%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.34%

其他

60.68%

股东类型

持股股东

占比

Investment Advisor

64.61%

Investment Advisor/Hedge Fund

23.75%

Hedge Fund

5.78%

Research Firm

2.96%

Pension Fund

2.15%

Sovereign Wealth Fund

1.60%

Bank and Trust

1.22%

Individual Investor

0.30%

Private Equity

0.09%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

1522

71.86M

102.08%

-3.62M

2025Q2

1541

72.80M

103.47%

-3.81M

2025Q1

1569

72.82M

103.50%

-3.52M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

8.68M

12.33%

+38.89K

+0.45%

Jun 30, 2025

Fidelity Management & Research Company LLC

6.86M

9.74%

-271.19K

-3.80%

Jun 30, 2025

Capital Research Global Investors

4.74M

6.73%

-1.34M

-22.06%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

4.35M

6.18%

-13.40K

-0.31%

Jun 30, 2025

State Street Investment Management (US)

3.06M

4.34%

+32.74K

+1.08%

Jun 30, 2025

Baillie Gifford & Co.

2.14M

3.03%

-115.69K

-5.14%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.93M

2.74%

+58.31K

+3.12%

Jun 30, 2025

ClearBridge Investments, LLC

1.54M

2.18%

+56.63K

+3.83%

Jun 30, 2025

American Century Investment Management, Inc.

1.31M

1.86%

+157.07K

+13.63%

Jun 30, 2025

Fidelity International

1.13M

1.61%

-155.38K

-12.09%

Jun 30, 2025

持股ETF



更新时间: 10月6日周一

机构名称

占比

Langar Global HealthTech ETF

6.89%

First Trust Nasdaq Lux Digi Health Solutions ETF

4.97%

Goldman Sachs Future Health Care Equity ETF

4.91%

Global X HealthTech ETF

4.42%

Fidelity Digital Health ETF

4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

3.4%

Congress SMid Growth ETF

2.99%

iShares U.S. Medical Devices ETF

2.74%

iShares Health Innovation Active ETF

2.64%

FT Raymond James Multicap Growth Equity ETF

2.54%

Langar Global HealthTech ETF

占比6.89%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比4.97%

Goldman Sachs Future Health Care Equity ETF

占比4.91%

Global X HealthTech ETF

占比4.42%

Fidelity Digital Health ETF

占比4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

占比3.4%

Congress SMid Growth ETF

占比2.99%

iShares U.S. Medical Devices ETF

占比2.74%

iShares Health Innovation Active ETF

占比2.64%

FT Raymond James Multicap Growth Equity ETF

占比2.54%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据